The Diagnostic Value of Liver Biopsy for Unexplained Liver Dysfunction: A Retrospective Study
DOI: https://doi.org/10.2147/jmdh.s460338
2024-05-18
Journal of Multidisciplinary Healthcare
Abstract:Ruifang Shi, 1, &ast Fan Yang, 1, &ast Hongli Wu, 2 Yonggang Liu 1 1 Department of Pathology, Tianjin Institute of Hepatology, Tianjin Second People's Hospital, Tianjin, 300192, People's Republic of China; 2 Department of Clinical Lab, Tianjin Institute of Hepatology, Tianjin Second People's Hospital, Tianjin, 300192, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yonggang Liu, Department of Pathology, Tianjin Institute of Hepatology, Tianjin Second People's Hospital, No. 7, Sudi South Road, Nankai District, Tianjin, 300192, People's Republic of China, Tel +86 22 27426025, Email Objective: To analyse clinical manifestations of unexplained abnormal liver function and perform hepatobiliary histopathology procedures on patients to evaluate the value of liver biopsy in diagnosing the aetiology of unexplained abnormal liver function. Methods: A convenience sampling method was used to retrospectively collect the data of patients who were diagnosed with unexplained abnormal liver function and who received liver biopsy in the Pathology Department of Tianjin Second People's Hospital, China, between March 2022 and July 2023 to analyse liver pathology and clinical manifestations. Results: A total of 1302 patients were included in this study, which mainly included 11 diseases: autoimmune liver disease (74 cases, 5.68%), drug-induced liver injury (DILI) (204 cases, 15.67%), cancer (237 cases, 18.20%), non-alcoholic fatty liver disease (104 cases, 7.99%), non-alcoholic steatohepatitis (74 cases, 5.68%), viral hepatitis (490 cases, 37.63%), other types of hepatitis (30 cases, 2.30%), cholestatic liver disease (17 cases, 1.31%), alcoholic liver disease (15 cases, 1.15%), hepatic cyst (5 cases, 0.38%) and Gilbert syndrome (4 cases, 0.31%). The success rate of liver biopsy sampling was 100%, and (1.52 ± 0.130) tissue strips were sampled. The average operating time was 11.52 minutes. The percutaneous liver biopsy did not significantly increase short-term liver function index values (serum γ-glutamyl transpeptidase, total bilirubin, alanine transaminase, aspartate aminotransferase, alkaline phosphatase). Ninety-two patients had a small amount of liver subcapsular fluid, but there was no progress after medical treatment. Conclusion: Ultrasound-guided percutaneous liver biopsy has value in the diagnosis of unexplained abnormal liver function. Viral hepatitis, cancer and DILI are the most common causes of unexplained abnormal liver function. Liver biopsy does not aggravate the organic and functional impairment of the liver. Keywords: unexplained abnormal liver function, clinical manifestations, liver biopsy, pathology The liver, an important organ in the human body, has the primary functions of metabolism, biotransformation, detoxification and coagulation. Moreover, the liver has an extremely strong compensatory ability. Most people have no symptoms before being diagnosed with abnormal liver function. Thus, abnormal liver function has become the "largest invisible killer". The main causes of abnormal liver function are viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), cholestasis, drug or poison damage, autoimmune liver disease, hepatobiliary malignancies and infections. Results show that alcohol is the most serious risk factor, and cirrhosis mortality is an effective indicator of the health consequences of alcohol abuse 1 and is most severe in Europe. 2 In addition to alcohol, infection with the hepatitis B (HBV) and C viruses (HBV and HCV, respectively) is a leading cause of cirrhosis. According to the World Health Organization's 2017 hepatitis report, 96% of the 1.3 million global deaths from hepatitis viruses are due to HBV and HCV infections, and more than half of these cases occur in the cirrhosis stage. 3 In Asia, the prevalence of HBV infection is higher among patients with cirrhosis than the prevalence of HCV, while in Europe and the US, the prevalence of HCV is higher than that of HBV. 4 China has the highest HBV infection burden in Asia, and although the prevalence of HBV in China has decreased in the past 40 years, the prevalence of hepatitis B surface antigen (HBsAg) in some subpopulations is still high in China. 5 Furthermore, intravenous drug users are at relatively high risk of contracting hepatitis C, and those who have been previously infected with this disease but have not been cured account for the majority of existing patients. 6 China is a high epidemic area for viral hepatitis. Viral hepatitis is the most common cause of clinically abnormal liver function, and the resulting mortalit -Abstract Truncated-
health care sciences & services